MCF Advisors’s Monogram Orthopaedics MGRM Stock Holding History

MCF Advisors’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-652	Closed	-$3.83K	–	1170
2025 Q3	$3.83K	Hold	652	–	–	﹤0.01%	827
2025 Q2	$1.89K	Hold	652	–	–	﹤0.01%	815
2025 Q1	$1.92K	Hold	652	–	–	﹤0.01%	815
2024 Q4	$1.55K	Hold	652	–	–	﹤0.01%	870
2024 Q3	$1.73K	Hold	652	–	–	﹤0.01%	860
2024 Q2	$1.4K	Hold	652	–	–	﹤0.01%	878
2024 Q1	$1.59K	Hold	652	–	–	﹤0.01%	841
2023 Q4	$2.24K	Hold	652	–	–	﹤0.01%	763
2023 Q3	$1.7K	Hold	652	–	–	﹤0.01%	783
2023 Q2	$2.6K	Buy	+652	New	+$3.37K	﹤0.01%	685

MCF Advisors's MGRM Position: Q4 2025 in Review

MCF Advisors sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 652 shares — an estimated $3.83K sold.

MCF Advisors first reported a position in MGRM in Q2 2023 and held it in 10 quarters. The position peaked at $3.83K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

MCF Advisors reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
MCF Advisors sold 652 Monogram Orthopaedics shares in Q4 2025, an estimated $3.83K.
MCF Advisors first reported a position in Monogram Orthopaedics in Q2 2023 and held it in 10 quarters.
MCF Advisors's Monogram Orthopaedics position peaked at $3.83K in Q3 2025.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on MCF Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.